Iron Deficiency Anemia Therapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Iron Deficiency Anemia Therapy Market will register over 6.5% CAGR between 2024 and 2032, with increasing awareness about the prevalence and consequences of the disease. Moreover, the market is expanding due to advancements in medical technology and the introduction of innovative iron supplementation products.

The increasing prevalence of chronic diseases, including gastrointestinal disorders that hinder iron absorption, amplifies the demand for specialized treatment options. The rising emphasis on preventive healthcare and personalized medicine bolsters the market growth by advocating for tailored therapeutic approaches.

The iron deficiency anemia therapy market categorizes itself based on type, therapy areas, age group, distribution channel, and region.

Due to its convenience and ease of administration, the oral iron segment is poised for notable growth during 2024-2032. Oral iron therapies present a non-invasive, self-administered choice, allowing patients to take them comfortably at home. This not only boosts patient adherence but also emphasizes comfort. Both patients and healthcare providers increasingly favor cost-effective treatments, enhancing the allure of oral iron supplements, which are generally more affordable. The push for accessible and user-friendly treatment options further amplifies the demand for oral iron products.

By 2032, the online pharmacy segment is set to command a substantial share of the iron deficiency anemia therapy market, thanks to its enhanced accessibility and convenience for consumers. E-commerce platforms have simplified the process for patients to acquire iron deficiency treatments, eliminating the need for physical pharmacy visits.

The ease of access is especially advantageous for those in remote or underserved regions. Additionally, online channels frequently provide a wider selection and competitive pricing, potentially boosting adoption rates and fueling overall market growth. The benefits of home delivery and the capability to swiftly compare products and prices further elevate the attractiveness of online pharmacies.

North America iron deficiency anemia therapy market is on track for impressive growth through 2032, driven by its advanced healthcare infrastructure and heightened awareness of anemia-related health concerns. Rising healthcare expenditures, coupled with a strong emphasis on preventive care, ensure better access to anemia treatments and facilitate early diagnoses.

The ongoing research and development in anemia therapies across the region, alongside government initiatives addressing public health challenges, will bolster the market outlook. The growing prevalence of dietary-related anemia and chronic health issues exacerbating iron deficiency further fuels the demand for effective therapeutic solutions.

Product Code: 10321

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of iron deficiency anemia
  - 3.2.1.2 Increasing awareness towards timely diagnosis
  - 3.2.1.3 Advancements in treatment options
  - 3.2.1.4 Growing geriatric population
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of advanced therapies
  - 3.2.2.2 Availability of alternative treatment options
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
- 3.6.1 By region
- 3.6.2 By key player
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Oral iron
5.3 Intravenous (IV) iron

Chapter 6 Market Estimates and Forecast, By Therapy Areas, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Inflammatory bowel disease
6.3 Renal
6.4 Obstetrics and gynecology
6.5 Congestive heart failure (CHF)
6.6 Oncology
6.7 Other therapy areas

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Adults
7.3 Pediatric
7.4 Geriatric

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospital pharmacy
8.3 Retail pharmacy
8.4 Online pharmacy

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Abbott Laboratories
10.2 AbbVie Inc.
10.3 AdvaCare Pharma
10.4 Akebia Therapeutics, Inc.
10.5 Bayer AG
10.6 Covis Pharma GmbH
10.7 CSL Limited
10.8 F. Hoffmann-La Roche Ltd.
10.9 GSK plc
10.10 Johnson and Johnson
10.11 Novartis AG
10.12 PHARMACOSMOS A/S
10.13 Pfizer Inc.
10.14 Sanofi
10.15 SK Capital Partners
10.16 Zydus Lifesciences Limited